US HB5400 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on December 11 2019 - 25% progression, died in committee
Action: 2019-12-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; (4) early-career scientists, including researchers from traditionally underrepresented groups; and (5) other innovative research. The bill also requries annual reporting about the fund by the NIH, the FDA, and the Department of the Treasury.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

National Biomedical Research Act

Sponsors


History

DateChamberAction
2019-12-12HouseReferred to the Subcommittee on Health.
2019-12-11HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-12-11HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-12-11HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-12-11HouseIntroduced in House

Subjects

Administrative law and regulatory procedures
Aging
Appropriations
Budget deficits and national debt
Cancer
Child health
Computers and information technology
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Education programs funding
Environmental health
Executive agency funding and structure
Food and Drug Administration (FDA)
Genetics
Government trust funds
Health
Health care costs and insurance
Health information and medical records
Health personnel
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Immunology and vaccination
Medicaid
Medical education
Medical research
Medical tests and diagnostic methods
Medicare
Military medicine
Minority health
National Institutes of Health (NIH)
Neurological disorders
Nutrition and diet
Physical fitness and lifestyle
Poverty and welfare assistance
Research administration and funding

US Congress State Sources


Bill Comments

feedback